Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.130
+0.290 (7.55%)
At close: Jun 26, 2026, 4:00 PM EDT
4.040
-0.090 (-2.18%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Ironwood Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Ironwood Pharmaceuticals stock have an average target of 7.50, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 81.60% from the current stock price of 4.13.
Analyst Consensus: Buy
* Price targets were last updated on May 6, 2026.
Analyst Ratings
The average analyst rating for Ironwood Pharmaceuticals stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Jan '26 | Feb '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 5 | 5 | 4 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $5 | Hold | Maintains | $5 | +21.07% | May 6, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +142.13% | Feb 26, 2026 |
Financial Forecast
Revenue This Year
459.48M
from 296.15M
Increased by 55.15%
Revenue Next Year
478.35M
from 459.48M
Increased by 4.11%
EPS This Year
1.09
from 0.25
Increased by 336.00%
EPS Next Year
1.44
from 1.09
Increased by 32.11%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 463.5M | 488.9M | |
| Avg | 459.5M | 478.4M | |
| Low | 452.0M | 467.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 56.5% | 6.4% | |
| Avg | 55.1% | 4.1% | |
| Low | 52.6% | 1.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 1.09 | 1.44 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 336.0% | 32.1% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.